Literature DB >> 19667262

Long-term response in primary renal cancer to sequential antiangiogenic therapy.

Nicholas J Vogelzang, Wolfram Samlowski, Alan Weissman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19667262     DOI： 10.1200/JCO.2009.23.4021

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Immunological heterogeneity of the RCC microenvironment: do targeted therapies influence immune response?

Authors:  Axel Bex; Tamara Etto; Florry Vyth-Dreese; Christian Blank; Arjan W Griffioen
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

2.  Presurgical neoadjuvant targeted molecular therapy for kidney cancer with concomitant vena cava tumor embolus: A clinical study.

Authors:  Gang Guo; Wei Cai; Hongzhao Li; Jiangping Gao; Xin Ma; Jun Dong; Weijun Fu; Xu Zhang
Journal:  Oncol Lett       Date:  2017-05-05       Impact factor: 2.967

Review 3.  Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities.

Authors:  Axel Bex; James Larkin; Christian Blank
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

4.  Is there a role for neoadjuvant targeted therapy to downsize primary tumors for organ sparing strategies in renal cell carcinoma?

Authors:  A Bex; B K Kroon; R de Bruijn
Journal:  Int J Surg Oncol       Date:  2012-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.